CT concluded that at
1 year in class C2 patients, no additional clinical benefit could
be observed when SEPS was added to HL/S.
This finding was supported by a prospective study by
van Neer et al362 in 62 limbs with class C2 disease, who had
varicose veins distal to the knee and underwent HL/S of
the GSV to the level of the knee. Clinical and ultrasonographic residual varicose veins at 6